PubHawk
Addiction February 2024 PMID 37816665

Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals.

Greta A Bushnell, Moira A Rynn, Tobias Gerhard, Katherine M Keyes, Deborah S Hasin, Magdalena Cerdá, Abner Nyandege, Mark Olfson

Download social card

Mentions

8
Peak: 3 in Oct 2023
across 3 sources since Oct 2023

Extended reach

19,687
potential audience

Total likes

2

Video views

38

Mentions per month

Oct 2023 – May 2024

Where it's discussed

  • X / Twitter4 posts
  • YouTube2 videos
  • Blogs2 articles

AI synopsis

What people are saying

Discussions largely agree with the study's conclusions, as seen in posts that highlight the increased overdose risks associated with benzodiazepine use, especially when combined with SSRIs, and the need for stricter monitoring and regulation. The tone varies from supportive to urgent, emphasizing the public health implications and calling for more cautious prescribing, demonstrating both high interest and engagement.

AgreementModerate agreement

Most discussions accept the findings, especially highlighting the increased overdose risks linked to benzodiazepine use in young adults.

InterestHigh interest

The topic resonates strongly with public health concerns, drawing significant attention and concern from the community.

EngagementModerate engagement

Posts respond with thoughtful commentary, referencing policy implications and medical practices, indicating moderate to high engagement.

ImpactHigh impact

Users emphasize the importance of the study, noting its potential to influence prescribing practices and regulations, reflecting a high perceived impact.

Abstract in brief

  • Benzodiazepines (BZDs) pose a significant risk for drug overdose among young adults treated for anxiety or depression, especially when used alone or combined with SSRIs.
  • The study found that young adults starting BZD treatment had a higher risk of overdose compared to those starting SSRI treatment alone, with roughly 1.36 to 1.59 times increased risk depending on the insurance type.
  • Combining BZDs with SSRIs (BZD-SSRI) was associated with an even greater overdose risk, nearly doubling the danger compared to SSRI treatment alone in both privately and publicly insured young adults.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Addiction Journal
@AddictionJrnl · X

Read the open access study by @GretaBushnell and colleagues here https://t.co/R0ulDjO1Sz https://t.co/PN8vGrSQsv

Oct 13, 2023 · 1 like · 15,019 followers View post →
Duke Psychiatry & Behavioral Sciences
@DukePsychiatry · X

Study co-authored by Duke Psychiatry chair Dr. Moira Rynn found that initiating benzodiazepine treatment for anxiety & depression in young U.S. adults, alone or w/SSRIs, appears to have ⬆️ risk of medically treated drug OD compared w/just SSRI treatment. https://t.co/Hx3niSIAWL https://t.co/tyVnJWoEjA

Jan 23, 2024 · 4,565 followers View post →
Medicaid Updates
@MedicaidUpdate · X

Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. (Addiction)

Oct 17, 2023 · 33 followers View post →
Medicaid Updates
@MedicaidUpdate · X

These findings have important implications for Medicaid, as it suggests the need for careful monitoring and potentially stricter regulations around BZD usage in this vulnerable population. Date of Publication: 2023 Oct 10 https://t.co/fnchaJYqfG #Medicaid

Oct 17, 2023 · 33 followers View post →

All mentions

Duke Psychiatry & Behavioral Sciences
@DukePsychiatry · X

Study co-authored by Duke Psychiatry chair Dr. Moira Rynn found that initiating benzodiazepine treatment for anxiety & depression in young U.S. adults, alone or w/SSRIs, appears to have ⬆️ risk of medically treated drug OD compared w/just SSRI treatment. https://t.co/Hx3niSIAWL https://t.co/tyVnJWoEjA

Jan 23, 2024 · 4,565 followers View post →
Medicaid Updates
@MedicaidUpdate · X

These findings have important implications for Medicaid, as it suggests the need for careful monitoring and potentially stricter regulations around BZD usage in this vulnerable population. Date of Publication: 2023 Oct 10 https://t.co/fnchaJYqfG #Medicaid

Oct 17, 2023 · 33 followers View post →
Medicaid Updates
@MedicaidUpdate · X

Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. (Addiction)

Oct 17, 2023 · 33 followers View post →
Addiction Journal
@AddictionJrnl · X

Read the open access study by @GretaBushnell and colleagues here https://t.co/R0ulDjO1Sz https://t.co/PN8vGrSQsv

Oct 13, 2023 · 1 like · 15,019 followers View post →